rs16873582
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The ENST00000422774.2(KIAA1549):c.3036C>T(p.Ser1012=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.075 in 1,602,556 control chromosomes in the GnomAD database, including 4,849 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.084 ( 542 hom., cov: 33)
Exomes 𝑓: 0.074 ( 4307 hom. )
Consequence
KIAA1549
ENST00000422774.2 synonymous
ENST00000422774.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.951
Genes affected
KIAA1549 (HGNC:22219): (KIAA1549) The protein encoded by this gene belongs to the UPF0606 family. This gene has been found to be fused to the BRAF oncogene in many cases of pilocytic astrocytoma. The fusion results from 2Mb tandem duplications at 7q34. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 7-138911255-G-A is Benign according to our data. Variant chr7-138911255-G-A is described in ClinVar as [Benign]. Clinvar id is 1165056.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.951 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.121 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KIAA1549 | NM_001164665.2 | c.3036C>T | p.Ser1012= | synonymous_variant | 4/20 | ENST00000422774.2 | NP_001158137.1 | |
KIAA1549 | NM_020910.3 | c.3036C>T | p.Ser1012= | synonymous_variant | 4/20 | NP_065961.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KIAA1549 | ENST00000422774.2 | c.3036C>T | p.Ser1012= | synonymous_variant | 4/20 | 1 | NM_001164665.2 | ENSP00000416040 | A2 | |
KIAA1549 | ENST00000440172.5 | c.3036C>T | p.Ser1012= | synonymous_variant | 4/20 | 1 | ENSP00000406661 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0835 AC: 12709AN: 152130Hom.: 541 Cov.: 33
GnomAD3 genomes
AF:
AC:
12709
AN:
152130
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0670 AC: 15638AN: 233480Hom.: 600 AF XY: 0.0674 AC XY: 8490AN XY: 126018
GnomAD3 exomes
AF:
AC:
15638
AN:
233480
Hom.:
AF XY:
AC XY:
8490
AN XY:
126018
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0741 AC: 107534AN: 1450308Hom.: 4307 Cov.: 31 AF XY: 0.0738 AC XY: 53140AN XY: 720358
GnomAD4 exome
AF:
AC:
107534
AN:
1450308
Hom.:
Cov.:
31
AF XY:
AC XY:
53140
AN XY:
720358
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0836 AC: 12721AN: 152248Hom.: 542 Cov.: 33 AF XY: 0.0818 AC XY: 6091AN XY: 74446
GnomAD4 genome
AF:
AC:
12721
AN:
152248
Hom.:
Cov.:
33
AF XY:
AC XY:
6091
AN XY:
74446
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
208
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Retinal dystrophy Benign:1
Benign, criteria provided, single submitter | research | Dept Of Ophthalmology, Nagoya University | Oct 01, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at